DeutschNewstral
Article
bizjournals.com on 2017-09-26 14:30
Mallinckrodt completes $425 million deal
Related news
- Mallinckrodt acquires InfaCare in deal worth up to $425 millionbizjournals.com
- Mallinckrodt closes $185 million dealbizjournals.com
- Mallinckrodt wraps up $203 million dealbizjournals.com
- Mallinckrodt wraps up $42 million dealbizjournals.com
- Mallinckrodt sells Intrathecal Therapy business in $203 million dealbizjournals.com
- Mallinckrodt to sell hemostasis products in $185 million dealbizjournals.com
- Mallinckrodt licenses inhalation treatment gas in deal worth up to $35 millionbizjournals.com
- Mallinckrodt acquires pharmaceutical firm for $42 millionbizjournals.com
- Mallinckrodt finalizes $35 million settlement with DEAbizjournals.com
- Mallinckrodt CEO sells $1.08 million Chesterfield homebizjournals.com
- Mallinckrodt enters $21 million equity purchase agreement with Mesoblastbizjournals.com
- Mallinckrodt buys three products in surgical portfolio for $175 millionbizjournals.com
Bankrupt opioid manufacturer Mallinckrodt will pay Colorado $18 millionDenver Post- Mallinckrodt subsidiaries to raise $750 million for acquisitionbizjournals.com
- Mallinckrodt to pay $100 million in settlement with FTCbizjournals.com
- Medicare spending on Mallinckrodt drug tops $500 millionbizjournals.com
- Mallinckrodt agrees to $35 million settlement with DEAbizjournals.com
- MMallinckrodt sells nuclear imaging business for $690 millionmarketwatch.com
- Medicare spent $650 million on one Mallinckrodt drug: Reportbizjournals.com
Mallinckrodt to pay $35M in deal to end feds’ opioid probejournalrecord.com